BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28874966)

  • 21. Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas.
    Miranda-Gonçalves V; Granja S; Martinho O; Honavar M; Pojo M; Costa BM; Pires MM; Pinheiro C; Cordeiro M; Bebiano G; Costa P; Reis RM; Baltazar F
    Oncotarget; 2016 Jul; 7(29):46335-46353. PubMed ID: 27331625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of CD147 and monocarboxylate transporters MCT1, MCT2 and MCT4 in porcine small intestine and colon.
    Sepponen K; Ruusunen M; Pakkanen JA; Pösö AR
    Vet J; 2007 Jul; 174(1):122-8. PubMed ID: 16901736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exercise-induced changes in tumour LDH-B and MCT1 expression are modulated by oestrogen-related receptor alpha in breast cancer-bearing BALB/c mice.
    Aveseh M; Nikooie R; Aminaie M
    J Physiol; 2015 Jun; 593(12):2635-48. PubMed ID: 25907793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monocarboxylate transporter 1 (MCT1) plays a direct role in short-chain fatty acids absorption in caprine rumen.
    Kirat D; Masuoka J; Hayashi H; Iwano H; Yokota H; Taniyama H; Kato S
    J Physiol; 2006 Oct; 576(Pt 2):635-47. PubMed ID: 16901943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of CD147 expression by RNA interference inhibits HT29 cell proliferation, invasion and tumorigenicity in vitro and in vivo.
    Li R; Pan Y; He B; Xu Y; Gao T; Song G; Sun H; Deng Q; Wang S
    Int J Oncol; 2013 Dec; 43(6):1885-94. PubMed ID: 24064772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation.
    Hanson DJ; Nakamura S; Amachi R; Hiasa M; Oda A; Tsuji D; Itoh K; Harada T; Horikawa K; Teramachi J; Miki H; Matsumoto T; Abe M
    Oncotarget; 2015 Oct; 6(32):33568-86. PubMed ID: 26384349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3-Bromopyruvate treatment induces alterations of metabolic and stress-related pathways in glioblastoma cells.
    Chiasserini D; Davidescu M; Orvietani PL; Susta F; Macchioni L; Petricciuolo M; Castigli E; Roberti R; Binaglia L; Corazzi L
    J Proteomics; 2017 Jan; 152():329-338. PubMed ID: 27890797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231.
    Gallagher SM; Castorino JJ; Wang D; Philp NJ
    Cancer Res; 2007 May; 67(9):4182-9. PubMed ID: 17483329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular features, regulation, and function of monocarboxylate transporters: implications for drug delivery.
    Enerson BE; Drewes LR
    J Pharm Sci; 2003 Aug; 92(8):1531-44. PubMed ID: 12884241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Organized metabolic crime in prostate cancer: The coexpression of MCT1 in tumor and MCT4 in stroma is an independent prognosticator for biochemical failure.
    Andersen S; Solstad Ø; Moi L; Donnem T; Eilertsen M; Nordby Y; Ness N; Richardsen E; Busund LT; Bremnes RM
    Urol Oncol; 2015 Aug; 33(8):338.e9-17. PubMed ID: 26066969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Diet Related Short-Chain Fatty Acids in Colorectal Cancer Metabolism and Survival: Prevention and Therapeutic Implications.
    Gomes SD; Oliveira CS; Azevedo-Silva J; Casanova MR; Barreto J; Pereira H; Chaves SR; Rodrigues LR; Casal M; Côrte-Real M; Baltazar F; Preto A
    Curr Med Chem; 2020; 27(24):4087-4108. PubMed ID: 29848266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status.
    Granja S; Marchiq I; Le Floch R; Moura CS; Baltazar F; Pouysségur J
    Oncotarget; 2015 Mar; 6(9):6708-21. PubMed ID: 25894929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression.
    Pinheiro C; Sousa B; Albergaria A; Paredes J; Dufloth R; Vieira D; Schmitt F; Baltazar F
    Histol Histopathol; 2011 Oct; 26(10):1279-86. PubMed ID: 21870331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The loop between helix 4 and helix 5 in the monocarboxylate transporter MCT1 is important for substrate selection and protein stability.
    Galić S; Schneider HP; Bröer A; Deitmer JW; Bröer S
    Biochem J; 2003 Dec; 376(Pt 2):413-22. PubMed ID: 12946269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance.
    Afonso J; Santos LL; Miranda-Gonçalves V; Morais A; Amaro T; Longatto-Filho A; Baltazar F
    Mol Carcinog; 2015 Nov; 54(11):1451-66. PubMed ID: 25263481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of lactate/proton symporters MCT1, MCT4, and their chaperone CD147 expressions in urothelial carcinoma of the bladder.
    Choi JW; Kim Y; Lee JH; Kim YS
    Urology; 2014 Jul; 84(1):245.e9-15. PubMed ID: 24857275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presence and localization of three lactic acid transporters (MCT1, -2, and -4) in separated human granulocytes, lymphocytes, and monocytes.
    Merezhinskaya N; Ogunwuyi SA; Mullick FG; Fishbein WN
    J Histochem Cytochem; 2004 Nov; 52(11):1483-93. PubMed ID: 15505343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation.
    Skaripa-Koukelli I; Hauton D; Walsby-Tickle J; Thomas E; Owen J; Lakshminarayanan A; Able S; McCullagh J; Carlisle RC; Vallis KA
    Cancer Metab; 2021 Oct; 9(1):37. PubMed ID: 34649623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis.
    Su J; Chen X; Kanekura T
    Cancer Lett; 2009 Jan; 273(1):140-7. PubMed ID: 18778892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting lactate transport suppresses in vivo breast tumour growth.
    Morais-Santos F; Granja S; Miranda-Gonçalves V; Moreira AH; Queirós S; Vilaça JL; Schmitt FC; Longatto-Filho A; Paredes J; Baltazar F; Pinheiro C
    Oncotarget; 2015 Aug; 6(22):19177-89. PubMed ID: 26203664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.